Tag Archives: Banner Sun Health Research Institute

The State of Dementia Research Globally: World Alzheimer Report 2018 (Alzheimer’s Disease International)

Posted on March 2, 2019 by Dementia and Elderly Care News

Summary The World Alzheimer Report 2018, entitled “The state of the art of dementia research: New frontiers”, reviews developments in dementia research, without glossing-over the absence of significant disease-modifying pharmacological treatment breakthroughs for around 20 years. This report examines wide-ranging … Continue reading →

Posted in Acute Hospitals, Alzheimer’s Disease International (ADI), Charitable Bodies, Community Care, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, Person-Centred Care, Quick Insights, Standards, Statistics, UK, Universal Interest | Tagged ADI’s World Alzheimer Reports, Alireza Atri: Director of Banner Sun Health Research Institute, Alzheimer's Research, Alzheimer’s Disease International (ADI), Alzheimer’s Disease Research Unit: McGill Centre for Studies in Ageing (Canada), Alzheimer’s Prevention Initiative: Banner Health (USA), Alzheimer’s Prevention Initiative: Banner Sun Health Research Institute, Banner Sun Health Research Institute, Burden of Alzheimer’s Disease, Burden of Dementia (Statistics), Centre for Dementia Prevention: University of Edinburgh, Dementia as Cause of Death, Dementia Awareness, Dementia Awareness Raising, Dementia Collaborative Research Centre: University of New South Wales, Dementia Discovery Fund, Dementia Discovery Fund (DDF), Dementia Prevention, Dementia Research, Dementia Research Funding, Dementia Research Priorities, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies for Dementia, Disease-Modifying Treatments for Dementia, Dr Christopher Chen: Director of Memory Ageing and Cognition Centre at National University Health System: Singapore, Dr Doug Brown: Chief Executive Officer of British Society for Immunology, Dr Doug Brown: Former Chief Policy and Research Officer at Alzheimer’s Society, Dr Jennifer Bute: Dementia Alliance International (DAI), Dr Kenji Toba: President of National Centre for Geriatrics and Gerontology (Obu), Dr Maria Carrillo: Chief Science Officer at Alzheimer’s Association US, Dr Miia Kivipelto: Karolinska Institute, Dr Miia Kivipelto: Karolinska University Hospital (Stockholm), Dr Rachelle Doody: Global Head of Neurodegeneration at Roche, Dr Serge Gauthier: Director of Alzheimer’s Disease Research Unit at McGill Centre for Studies in Ageing in Canada, Drug Trials Failure Rate, Epidemiology, Epidemiology and Statistics, Francesca Colombo: Organisation for Economic Co-operation and Development (OECD), Fundación para la Lucha contra las Enfermedades Neurológicas (FLENI), Glenn Rees: Chairman of Alzheimer’s Disease International, Glenn Rees: Former CEO of Alzheimer’s Australia, Global Burden of Dementia, Global Dementia Discovery Fund (2015), Identification and Intervention for Dementia in Elderly Africans (IDEA Group), Jeff Cummings: Director of Cleveland Clinic at Lou Ruvo Centre for Brain Health, Kate Bingham: SV Health Managers, King’s College London, Market Failure (Dementia Research and Drug Development), Martin Knapp: London School of Economics, Memory Ageing and Cognition Centre at National University Health System: Singapore, Memory Ageing and Cognition Centre: National University Health System (Singapore), National Centre for Geriatrics and Gerontology (Japan), Optima (University of Oxford’s Dementia Research Project), OPTIMA Cohort (Oxford Project to Investigate Memory and Ageing), Oxford Project to Investigate Memory and Ageing (OPTIMA Study), Paola Barbarino: Alzheimer’s Disease International, Prevention, Prevention Agenda, Prevention of Future Dementia Cases by Increasing Knowledge of Risk and Protective Factors, Professor Adesola Ogunniyi: University College Hospital (Ibadan), Professor Bart De Strooper: Director of the UK Dementia Research Institute (UK DRI), Professor Craig Ritchie: Chair of Psychiatry of Ageing at University of Edinburgh, Professor Craig Ritchie: Director at Centre for Dementia Prevention, Professor Gordon Wilcock: Co-founder of Alzheimer’s Society UK, Professor Gordon Wilcock: Emeritus Professor of Geratology at University of Oxford, Professor Henry Brodaty: Director of Dementia Collaborative Research Centre at University of New South Wales, Professor Martin Knapp: Director of the Personal Social Services Research Unit at the London School of Economics and Political Science (LSE), Professor Martin Prince: Assistant Principal for Global Health at King’s College London, Research Networks, Ricardo Allegri: Head of Cognitive Neurology Neuropsychology and Neuropsychiatry at Fundación para la Lucha contra las Enfermedades Neurológicas (FLENI), Risk and Protective Factors, State of the Art of Dementia Research: New Frontiers (World Alzheimer Report 2018), Supporting People Affected by Dementia, UK Dementia Research Institute, UK Dementia Research Institute (UK DRI), UK Dementia Research Institute at UCL, University College Hospital (Ibadan Nigeria), World Alzheimer Report, World Alzheimer Report 2018: State of the Art of Dementia Research, World Alzheimer Report: 2018, World Alzheimer’s Day 2018 | Leave a comment

Dementia with Lewy Bodies: Updated DLB Consortium Diagnosis and Management Consensus Report (Neurology)

Posted on July 13, 2017 by Dementia and Elderly Care News

Summary The Dementia with Lewy Bodies (DLB) Consortium has published an updated set of recommendations on diagnosis and management of DLB. Clinical features and diagnostic biomarkers are covered, with guidance on their interpretation. Previously omitted aspects of Lewy-related pathology are … Continue reading →

Posted in Antipsychotics, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Quick Insights, UK | Tagged Abnormal Proteins (Alpha-Synuclein), Acting Out Dreams: Rapid Eye Movement (REM) Sleep Behaviour Disorder, Alpha-Synuclein Aggregation, Alpha-Synucleinopathies, Alternatives to Antipsychotics, Antipsychotics Limitation in Dementia, Antipsychotics: Neuroleptic Sensitivity, Assessment and Diagnosis, Australia, Autonomic System Dysfunction, Banner Sun Health Research Institute, Behavior and Mood Changes, Behavioral and Psychological Symptoms of Dementia (BPSD), Behavioural and Psychological Symptoms of Dementia (BPSD), Biomarker Development, Biomarkers, Biomarkers Research Programmes, Blackouts, Brain and Mind Centre: University of Sydney, Brain Stimulation, Center for Neurodegenerative Disease Research: University of Pennsylvania, Centre for Age-Related Diseases: Stavanger University Hospital, Cognitive Decline (DLB vs. Alzheimer's), Cognitive Symptoms, Comparison of Cognitive Decline (DLB vs. AD), Deep Brain Stimulation for the Treatment of Dementia, Delusions, Dementia With Lewy Bodies (DLB), Dementia With Lewy Bodies (DLB) Consortium, Department of Laboratory Medicine and Pathology: Mayo Clinic, Department of Neurology: Mayo Clinic, Department of Neurology: Mayo Clinic (Rochester), Department of Neurology: University of Pennsylvania, Department of Neuroscience and Neuropathology Laboratory: Mayo Clinic, Department of Neuroscience Imaging and Clinical Sciences: University G. d'Annunzio of Chieti-Pescara, Department of Neuroscience: Mayo Clinic, Department of Psychiatry and Psychology: Mayo Clinic, Department of Veterans Affairs, Departments of Radiology and Neurology: University of Michigan, Diagnosis and Management of Dementia with Lewy Bodies, Diagnosis and Screening: Dementia with Lewy Bodies, Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-V), Differential Diagnosis, Dizziness, DLB, DLB Management, DLB: Dementia with Lewy Bodies, Drooling, DSM-5, Early Diagnosis, Early Diagnosis of Lewy Body Dementia (LBD), Early Diagnosis of Parkinson’s Disease and DLB, Fainting, Florida Atlantic University, Fluctuating Cognition, Fluctuations, Fourth Consensus Report of DLB Consortium, Hallucinations, Handwriting, ICube Laboratory, Institute for Healthy Aging and Lifespan Studies (I-HeAL): Florida Atlantic University, Institute of Neuroscience: Newcastle University, Institute of Psychiatry Psychology and Neuroscience: King’s College London, Italy, α-Synuclein, α-Synuclein Aggregation, α-Synuclein Misfolds, Kings College London, Lewy Body Degeneration, Lewy Body Dementia, Lewy Body Dementia (LBD), Lewy Body Dementia Symptoms Checklists, Lewy Body Society, Medical School: University of Exeter; University of Exeter, Misdiagnosis, Mood Changes, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neuroleptic Sensitivity, Neurology (Journal), Norway, Parkinson's Disease and Mental Illness Research Education and Clinical Centers (PADRECC and MIRECC): Philadelphia Veterans Affairs Medical Center, Parkinson’s-Like Symptoms, Perelman School of Medicine: University of Pennsylvania, Philadelphia Veterans Affairs Medical Center, Postural Instability, Preclinical Biomarkers and Dementia, Prion-Like Mechanisms, Repeated Falls, Severe Neuroleptic Sensitivity, Severe Sensitivity to Antipsychotic Agents, Shuffling Walk, Sleep Disorders Center: Mayo Clinic, Stavanger University Hospital, Stavanger University Hospital; Norway, Synucleinopathies, Synucleinopathy, Synucleinopathy Progression, Transient Loss of Consciousness, Underlying Mechanisms of DLB Pathogenesis, United States, University G. d'Annunzio of Chieti-Pescara, University Hospital of Strasbourg, University of Michigan, University of Pennsylvania, University of Strasbourg, University of Sydney | Leave a comment

Primary Age Related Tauopathy (PART): A New Type / Cause of Cognitive Impairment?

Posted on November 18, 2014 by Dementia and Elderly Care News

Summary The authors of this article propose the introduction of a new term to describe a pathology found to be commonly present in the brains of aged persons; namely “Primary Age-Related Tauopathy (PART). Autopsy studies indicate brains with neurofibrillary tangles … Continue reading →

Posted in Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Quick Insights, Systematic Reviews, Universal Interest | Tagged Acta Neuropathologica, Age and Ageing, Age-Related Pathologies, Ageing, Ageing and Dementia, Ageing Population, Amnestic MCI, Amnestic Mild Cognitive Impairment (a-MCI), Amnestic Mild Cognitive Impairment (aMCI), Banner Sun Health Research Institute, Biomarkers, Boston University, Civin Laboratory for Neuropathology: Banner Sun Health Research Institute, Cognitive Ageing, Cognitive Impairment, Columbia University, Columbia University Medical Center, Common Pathology Associated With Human Ageing, Department of Neuroscience: Mayo Clinic, Department of Pathology and Cell Biology: Columbia University Medical Center, Department of Pathology and Immunology: Washington University School of Medicine, Department of Physiology and Sanders-Brown Center on Aging: University of Kentucky, Departments of Pathology (Neuropathology) and Neurological Sciences: Rush University Medical Center, Division of Neuropathology: University of Pennsylvania, Emory University School of Medicine (Atlanta), Fishberg Department of Neuroscience and Friedman Brain Institute, Genetics and Pathology: Uppsala University, Harvard Medical School, Human Ageing Process, Icahn School of Medicine at Mount Sinai, Institute for Ageing and Health: Newcastle University, Institute of Clinical Neurobiology (Vienna), Kanazawa University Graduate School of Medical Sciences, Massachusetts General Hospital, Mayo Clinic, Mild Cognitive Impairment (MCI), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Research, Neurofibrillary Tangles, Neurofibrillary Tangles (NFTs), Neuropathologic Disorders, Neuropathology, New York University School of Medicine, Newcastle University, NFT+/Aβ- Brains (Neurofibrillary Tangles Without Amyloid [Aβ] Plaques), Northwestern Cognitive Neurology and Alzheimer Disease Center: Northwestern University Feinberg School of Medicine, Northwestern University Feinberg School of Medicine, Oregon Health Sciences University, PART: Primary Age-Related Tauopathy, Primary Age Related Tauopathy (PART), Rush University Medical Center (US), Rush University Medical Center: Chicago, Sanders-Brown Center on Aging, Screening for Cognitive Impairment, Tau, Tau Pathology, Tau Protein, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Tauopathy, Tokyo Metropolitan Geriatric Hospital, University of British Columbia, University of California, University of Iowa Hospitals and Clinics, University of Kentucky, University of Pennsylvania, University of Pennsylvania Perelman School of Medicine, University of Pittsburgh Medical Center, University of São Paulo, University of Texas Southwestern Medical School, University of Ulm, University of Washington, Uppsala University, VA Medical Center and Boston University School of Medicine, Washington University School of Medicine | Leave a comment

Rapid Eye Movement (REM) Sleep Behaviour Disorder May Predict Development of Dementia With Lewy Bodies (Mayo Clinic News)

Posted on March 21, 2013 by Dementia and Elderly Care News

Summary Rapid eye movement (REM) sleep behaviour disorder is caused by the loss of the normal muscle paralysis during REM sleep. This tendency to “act out dreams” can appear three decades or more before a formal diagnosis of dementia with Lewy bodies in males, … Continue reading →

Posted in Diagnosis, For Doctors (mostly), For Researchers (mostly), International, Quick Insights, Universal Interest | Tagged Acting Out Dreams: Rapid Eye Movement (REM) Sleep Behaviour Disorder, American Academy of Neurology, Association of RBD with Synucleinopathies, Banner Sun Health Research Institute, Braak Neurofibrillary Tangle (NFT) Stage, Center for Sleep Medicine: Mayo Clinic, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Dementia in Parkinson's Disease, Dementia with Lewy Bodies, Dementia With Lewy Bodies (DLB), Dementia with Lewy Bodies Symptoms, Department of Laboratory Medicine and Pathology: Mayo Clinic, Department of Neurology: Mayo Clinic, Department of Neuroscience and Neuropathology Laboratory: Mayo Clinic, Department of Neuroscience: Mayo Clinic, Department of Psychiatry and Psychology: Mayo Clinic, Department of Sleep Medicine: University Hospital of Montpellier, Diagnosis and Screening: Dementia with Lewy Bodies, Differential Diagnosis, DLB, DLB: Dementia with Lewy Bodies, Dream Enactment Behaviour During Sleep, Dreaming in Dementia: REM Sleep Behaviour Disorder and Synucleinopathy, Early Diagnosis, Early Differential Diagnosis, Fluctuating Cognition, Hallucinations, Hallucinations in People with Dementia, IDIBAPS, Lewy Body Degeneration, Lewy Body Dementia, Lewy-Related Pathologies (LRP), Magnetic Resonance Imaging (MRI), Mayo Clinic, Mayo Clinic News, Melissa Murray, Minnesota Regional Sleep Disorders Center, MRI, MRI Brain Imaging, MRI Scans, Multiple System Atrophy (MSA), Parkinson’s Disease Dementia, PDD: Parkinson's Disease with Dementia, Pierre and Marie Curie University, Pitié-Salpêtrière Hospital, Polysomnogram (PSG), Rapid Eye Movement (REM) Sleep, Rapid Eye Movement (REM) Sleep Behaviour Disorder, Rapid Eye Movement (REM) Sleep Disorder, Rapid Eye Movement Sleep Behaviour Disorder (RBD), RBD: Rapid Eye Movement Sleep Behaviour Disorder, Sleep Disorders, Sleep Disorders Center: Mayo Clinic, Synucleinopathies, United States, Universitat de Barcelona, University of Miami Miller School of Medicine, University of Minnesota, USA, Visual Hallucinations | Leave a comment

Tag Archives: Banner Sun Health Research Institute

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites